Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2006 1
2007 1
2008 4
2009 5
2010 4
2011 7
2012 8
2013 1
2014 2
2015 1
2016 16
2017 8
2018 3
2019 4
2020 11
2021 10
2022 7
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Cirrhotic Cardiomyopathy.
Yoon KT, Liu H, Lee SS. Yoon KT, et al. Curr Gastroenterol Rep. 2020 Jul 10;22(9):45. doi: 10.1007/s11894-020-00783-1. Curr Gastroenterol Rep. 2020. PMID: 32651721 Review.
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection.
Agarwal K, Brunetto M, Seto WK, Lim YS, Fung S, Marcellin P, Ahn SH, Izumi N, Chuang WL, Bae H, Sharma M, Janssen HLA, Pan CQ, Çelen MK, Furusyo N, Shalimar D, Yoon KT, Trinh H, Flaherty JF, Gaggar A, Lau AH, Cathcart AL, Lin L, Bhardwaj N, Suri V, Mani Subramanian G, Gane EJ, Buti M, Chan HLY; GS-US-320-0110; GS-US-320-0108 Investigators. Agarwal K, et al. Among authors: yoon kt. J Hepatol. 2018 Apr;68(4):672-681. doi: 10.1016/j.jhep.2017.11.039. Epub 2018 Jan 17. J Hepatol. 2018. PMID: 29756595 Clinical Trial.
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis.
Mak LY, Gane E, Schwabe C, Yoon KT, Heo J, Scott R, Lee JH, Lee JI, Kweon YO, Weltman M, Harrison SA, Neuschwander-Tetri BA, Cusi K, Loomba R, Given BD, Christianson DR, Garcia-Medel E, Yi M, Hamilton J, Yuen MF. Mak LY, et al. Among authors: yoon kt. J Hepatol. 2023 Apr;78(4):684-692. doi: 10.1016/j.jhep.2022.11.025. Epub 2022 Dec 10. J Hepatol. 2023. PMID: 36513186 Clinical Trial.
Pathogenic Mechanisms Underlying Cirrhotic Cardiomyopathy.
Liu H, Nguyen HH, Yoon KT, Lee SS. Liu H, et al. Among authors: yoon kt. Front Netw Physiol. 2022 Apr 19;2:849253. doi: 10.3389/fnetp.2022.849253. eCollection 2022. Front Netw Physiol. 2022. PMID: 36926084 Free PMC article. Review.
Advances in cirrhotic cardiomyopathy.
Liu H, Yoon KT, Zhang J, Lee SS. Liu H, et al. Among authors: yoon kt. Curr Opin Gastroenterol. 2021 May 1;37(3):187-193. doi: 10.1097/MOG.0000000000000733. Curr Opin Gastroenterol. 2021. PMID: 33756518 Review.
Primary Biliary Cholangitis with Ankylosing Spondylitis.
Hong YM, Yoon KT, Cho M. Hong YM, et al. Among authors: yoon kt. Korean J Gastroenterol. 2022 Jun 25;79(6):270-273. doi: 10.4166/kjg.2022.048. Korean J Gastroenterol. 2022. PMID: 35746842 Free article.
KASL clinical practice guidelines: management of hepatitis C.
Korean Association for the Study of the Liver. Korean Association for the Study of the Liver. Clin Mol Hepatol. 2016 Mar;22(1):76-139. doi: 10.3350/cmh.2016.22.1.76. Epub 2016 Mar 28. Clin Mol Hepatol. 2016. PMID: 27044763 Free PMC article. Review. No abstract available.
Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study.
Heo J, Kim YJ, Lee SW, Lee YJ, Yoon KT, Byun KS, Jung YJ, Tak WY, Jeong SH, Kwon KM, Suri V, Wu P, Jang BK, Lee BS, Cho JY, Jang JW, Yang SH, Paik SW, Kim HJ, Kwon JH, Park NH, Kim JH, Kim IH, Ahn SH, Lim YS. Heo J, et al. Among authors: yoon kt. Korean J Intern Med. 2023 Jul;38(4):504-513. doi: 10.3904/kjim.2022.252. Epub 2023 Jun 30. Korean J Intern Med. 2023. PMID: 37424500 Free PMC article. Clinical Trial.
96 results